Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan

Clinical trial NCT01263509 · COMPLETED

Trial details

NCT number: NCT01263509
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2007-06-01
Primary completion: 2008-10-01
Enrollment: 179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.